Drug Shortage Report for SANDOZ SENNA S
| Report ID | 139898 |
| Drug Identification Number | 02247390 |
| Brand name | SANDOZ SENNA S |
| Common or Proper name | SANDOZ SENNA S |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DOCUSATE SODIUM SENNOSIDES |
| Strength(s) | 50MG 8.6MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500FCT BO CA |
| ATC code | A06AB |
| ATC description | DRUGS FOR CONSTIPATION |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2021-05-21 |
| Estimated end date | 2021-11-12 |
| Actual end date | 2021-10-25 |
| Shortage status | Resolved |
| Updated date | 2021-10-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.